A review of preclinical evidence examining BPC-157’s proposed roles in spinal cord injury models, focusing on NF-kB-mediated neuroinflammation, axonal protection, and VEGF/eNOS vascular signaling pathways.

A research-context review of BPC-157 effects on intestinal tight junction assembly, enterocyte restitution, and mucosal repair signaling pathways in preclinical injury models.

This article examines preclinical research on BPC-157’s reported effects on FAK-paxillin, ERK1/2, and VEGFR2 signaling pathways in rodent tendon and ligament injury models, with attention to the significant gap between animal findings and clinical evidence.

A research-focused review of BPC-157 macrophage polarization findings, cytokine modulation patterns, and the boundaries of current immunomodulatory evidence in preclinical models.

A research-context review of BPC-157’s documented effects on peripheral nerve injury models, with attention to nerve fascicle organization, motor potential recovery, and vascularization in transection and compression injury studies.

A review of preclinical research on BPC-157’s modulation of endothelial nitric oxide synthase via the Src-Cav-1-eNOS signaling axis and downstream sGC-cGMP pathway activity.

Preclinical research overview of BPC-157 dopaminergic system modulation including nigrostriatal pathway protection and D1/D2 receptor interactions in rodent models.

A review of BPC-157 preclinical research in tendon fibroblast contexts, examining FAK-paxillin/ERK1/2 signaling, growth hormone receptor expression, angiogenic responses, and collagen remodeling observed in rodent Achilles transection models.

A review of BPC-157’s activity in cardiac ischemia-reperfusion preclinical models, focusing on RISK pathway PI3K/Akt/eNOS activation and myocardial nitric oxide signaling dynamics.

An analysis of BPC-157 gastric mucosal cytoprotection mechanisms in preclinical models, focusing on prostaglandin-independent pathways, NO synthase interactions, and EGR-1 transcription factor involvement.